LGHTvsIBBQETF Comparison
Langar Global HealthTech ETF (LGHT) belongs to the Healthcare Technology segment. Invesco Nasdaq Biotechnology ETF (IBBQ) is part of the US Health Care segment. LGHT's top 1 sector exposures are Healthcare. In contrast, IBBQ's top sector exposures are Healthcare and Non-Energy Materials. LGHT is more expensive with a Total Expense Ratio (TER) of 0.85%, versus 0.19% for IBBQ. LGHT is up 2.6% year-to-date (YTD) with -$1M in YTD flows. IBBQ performs better with 26.33% YTD performance, and +$17M in YTD flows. Run a side-by-side ETF comparison of LGHT and IBBQ below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
LGHT vs IBBQ performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | LGHT IBBQ | +15.51%+11.87% | +25.50%+22.38% | +2.60%+26.33% | +0.98%+51.52% | n/a+76.61% | n/a+37.75% |
| Flows | LGHT IBBQ | -+$14M | -$522K+$16M | -$1M+$17M | -$941K+$36M | -+$52M | -+$27M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | LGHT IBBQ | +38.13%+25.30% | +25.51%+21.55% | n/a+20.83% | n/a+22.05% |
| Max drawdown | LGHT IBBQ | -10.33%-6.21% | -25.58%-8.38% | n/a-23.78% | n/a-37.96% |
| Max drawdown duration | LGHT IBBQ | 32d31d | 309d48d | n/a375d | n/a1518d |
LGHT | IBBQ | |
Last sale 9/1/2026 at 7:59 PM | $35.80 | |
| Previous close 09/01/2026 | $35.47 | |
| Consolidated volume 09/01/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
LGHT | IBBQ | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
LGHT | IBBQ | |
|---|---|---|
| Last price | – | $35.80 |
| 1D performance | – | +0.92% |
| AuM | $2.36 M | $97.28 M |
| E/R | 0.85% | 0.19% |
LGHT | IBBQ | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Langar Investment Management | Invesco |
| Benchmark | - | NASDAQ Biotechnology Index |
| N° of holdings | 30 | 249 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 10, 2024 | June 9, 2021 |
| ESG | Yes | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
